Meiwu Technology and Real BioTech signed an MOU to collaboratively enhance market presence in the beauty industry.
Quiver AI Summary
Meiwu Technology Co., Ltd., a prominent player in the beauty industry, announced the signing of a non-binding Strategic Cooperation MOU with Real BioTech (Qingdao) Ltd. on November 25, 2025. This partnership aims to leverage the strengths of both companies to increase market share in the beauty sector both in China and globally. Meiwu, which focuses on the research, development, and sale of functional skincare products, will collaborate with Real Biotech, a marine biotechnology firm specializing in the development of products derived from marine resources. The agreement outlines that Real Biotech will provide R&D support and technical services to Meiwu, enhancing its ability to develop beauty solutions that incorporate marine active ingredients. This collaboration is anticipated to align with Meiwu's long-term strategy and unlock new opportunities in the evolving beauty market, ultimately benefiting customers, shareholders, and partners.
Potential Positives
- Meiwu Technology Co., Ltd. has signed a strategic cooperation MOU with Real BioTech, which could enhance its capabilities in the beauty sector by integrating marine biotechnology expertise.
- This partnership aims to expand Meiwu's market share in both the Chinese and global beauty markets, positioning the company for potential growth in a high-demand segment.
- The collaboration will leverage Real Biotech's R&D and technical services to improve the development of natural, science-backed skincare products, aligning with consumer trends towards efficacy and natural ingredients.
Potential Negatives
- The announcement of a non-binding MOU may indicate uncertainty in the company's future plans, as no concrete partnership details or commitments have been established.
- The reliance on a strategic partnership for growth could signal potential weaknesses in Meiwu's own capabilities or market position.
- The mention of risks and uncertainties in the forward-looking statements raises concerns about the company's ability to execute its strategy effectively in a competitive market.
FAQ
What is the purpose of Meiwu's MOU with Real BioTech?
The MOU aims to establish a strategic partnership to expand market shares in the beauty market in China and globally.
How will Meiwu and Real BioTech work together?
Both companies will integrate their strengths to drive growth in beauty solutions utilizing marine active ingredients.
What sector does Real BioTech specialize in?
Real BioTech specializes in marine biotechnology development, including products such as cosmetics and medical devices.
What is Meiwu's primary focus?
Meiwu focuses on R&D, packaging, promotion, and sales of functional skincare products.
What benefits are expected from this partnership?
The partnership is expected to enhance Meiwu's capabilities and capture new opportunities in the evolving beauty industry.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$WNW Hedge Fund Activity
We have seen 1 institutional investors add shares of $WNW stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RENAISSANCE TECHNOLOGIES LLC added 13,500 shares (+inf%) to their portfolio in Q3 2025, for an estimated $26,595
- UBS GROUP AG removed 2,878 shares (-99.9%) from their portfolio in Q3 2025, for an estimated $5,669
- SBI SECURITIES CO., LTD. removed 1,473 shares (-48.7%) from their portfolio in Q3 2025, for an estimated $2,901
- HRT FINANCIAL LP removed 1,338 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $2,603
- CITADEL ADVISORS LLC removed 711 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $1,383
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Xiamen, China, Dec. 03, 2025 (GLOBE NEWSWIRE) -- Meiwu Technology Co., Ltd. (hereinafter referred to as " Meiwu" or the "Company") (NASDAQ: WNW), a leading integrated platform in the beauty industry, announced that the Company signed a non-binding Strategic Cooperation Memorandum of Understanding ("MOU") on November 25, 2025, with Real BioTech (Qingdao) Ltd. ("Real Biotech"), a marine biotechnology enterprise based in Qingdao, China. The MOU aims to establish a strategic partnership between the two parties, jointly dedicated to expanding the Company’s market shares in the beauty market in China and globally.
Pursuant to the terms of the MOU, both parties will integrate their core strengths and resources to drive synergistic growth:
- Meiwu operates as a platform integrating R&D, packaging, promotion, sales of functional skincare products, and talent training for retail stores.
- Real Biotech specializes in marine biotechnology development and promotion; R&D, production, and sales of food, medical devices, cosmetics, marine biological hemostatic materials, and wound dressings; as well as the cultivation, processing, and sales of marine microalgae.
Through this strategic cooperation, Real Biotech plans to leverage its R&D capabilities and marine biological resources to provide Meiwu with R&D support, technical services, and technical consulting. Meiwu believes this collaboration will enhance its capabilities in the beauty sector, particularly in the development of beauty solutions utilizing marine active ingredients, which the Company believes is a high-growth segment in the global beauty market driven by increasing consumer demand for natural, science-backed skincare products.
The Company believes that this partnership aligns with Meiwu’s long-term strategy. By combining Real Biotech’s expertise in marine biotechnology with Meiwu’s brand operation and distribution network, the Company believes that the two parties are positioned to capture new opportunities in the rapidly evolving beauty industry, delivering enhanced value to customers, shareholders, and partners alike.
About Meiwu Technology Co., Ltd. (NASDAQ: WNW)
Meiwu Technology Co., Ltd. is committed to providing high-quality functional skincare products and professional services through its subsidiaries in China. For more information, please visit the Company’s official website:
www.wnw108.com
.
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, statements regarding the expected benefits of the strategic cooperation, the expansion of the efficacious beauty market, and the Company’s future business development. These statements are based on current expectations, estimates, and projections of the Company’s management, and involve certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements. Factors that may affect actual results include, but are not limited to, changes in market conditions, regulatory developments, the ability to successfully implement the cooperation plan, and other risks and uncertainties described in the Company’s filings with the U.S. Securities and Exchange Commission (SEC). The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
Contact
Meiwu Technology Company Limited
Zhichao Yang
Email:
[email protected]
